UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

BMC cancer, 2022-12, Vol.22 (1), p.1348-1348, Article 1348

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

BMC cancer, 2022-09, Vol.22 (1), p.960-10, Article 960

2022

Link zum Volltext

Verfügbarkeit prüfen

Alvopem ® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

Journal of pharmaceutical policy and practice, 2023-01, Vol.16 (1), p.16-16, Article 16

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Mixed-phenotype acute leukemia characteristics: first report from Iran

Clinical and experimental medicine, 2021-05, Vol.21 (2), p.341-341

2021

Link zum Volltext

Verfügbarkeit prüfen

Proteomic and genomic biomarkers for Non‐Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha‐1 antitrypsin

Cancer medicine (Malden, MA), 2020-06, Vol.9 (11), p.3974-3982

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating free DNA concentration as a marker of disease recurrence and metastatic potential in lung cancer

Clinical and translational medicine, 2019-04, Vol.8 (1), p.1-6

2019

Link zum Volltext

Verfügbarkeit prüfen

Mixed-phenotype acute leukemia characteristics: first report from Iran

Clinical and experimental medicine, 2018-11, Vol.18 (4), p.513-521

2018

Link zum Volltext

Verfügbarkeit prüfen

Correlation of Minichromosome Maintenance Protein 6 Expression Rate and Clinical Outcome in Patients With Hodgkin's Lymphoma

Acta medica Iranica, 2017-09, Vol.55 (9), p.550-555

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin Free Light Chains in the Pathogenesis of Lung Disorders

Iranian journal of allergy, asthma, and immunology, 2017-08, Vol.16 (4), p.282-288

2017

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer gender differences: An analysis of 1599 patients diagnosed between 1996 and 2018

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13596-e13596

2020

Link zum Volltext

Verfügbarkeit prüfen

Cancers Related to Immunodeficiencies: Update and Perspectives

Frontiers in immunology, 2016-09, Vol.7, p.365-365

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the safety and effectiveness of PegaGen.sup.® for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study

Supportive care in cancer, 2022-10, Vol.30 (10), p.8151

2022

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Potential of Diet and Odds of Lung Cancer: A Case-Control Study

Nutrition and cancer, 2022, Vol.74 (8), p.2859-2867

2022

Link zum Volltext

Verfügbarkeit prüfen

IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma

International journal of hematology- oncology and stem cell research, 2011-09, Vol.5 (3)

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical Effectiveness of Erlova in EGFR-Mutated Non-Small Cell Lung Cancer: An Affordable Price with Clinical Benefit

Asian Pacific journal of cancer prevention : APJCP, 2022-04, Vol.23 (4), p.1155-1158

2022

Link zum Volltext

Verfügbarkeit prüfen

EPA and DHA have selective toxicity for PBMCs from multiple myeloma patients in a partly caspase-dependent manner

Clinical nutrition (Edinburgh, Scotland), 2020-07, Vol.39 (7), p.2137-2143

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the safety and effectiveness of PegaGen® (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study

Supportive care in cancer, 2022-10, Vol.30 (10), p.8151-8158

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome of Hodgkin lymphoma: A single center study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e19515-e19515

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive discrimination of adenocarcinoma and squamous cell carcinoma based on differential expression of miR-944 and miR-326 in sputum samples of lung cancer patients

Human Gene, 2024-05, Vol.40, Article 201273

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients

Clinical biochemistry, 2017-04, Vol.50 (6), p.293-300

2017

Link zum Volltext

Verfügbarkeit prüfen

Relapse of acute myeloid leukemia as isolated bilateral testicular granulocytic sarcoma in an adult

Urology journal, 2008, Vol.5 (2), p.132-135

2008

Link zum Volltext

Verfügbarkeit prüfen

Cell Free Tumoral DNA Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients with Non-Small Cell Lung Cancer

Asian Pacific journal of cancer prevention : APJCP, 2019-12, Vol.20 (12), p.3591-3596

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical Benefit

Asian Pacific journal of cancer prevention : APJCP, 2018-10, Vol.19 (10), p.2973-2978

2018

Link zum Volltext

Verfügbarkeit prüfen

Dietary Intake and Serum Level of Carotenoids in Lung Cancer Patients: A Case-Control Study

Nutrition and cancer, 2015-08, Vol.67 (6), p.893-898

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(60)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Humans
(22)
Life Sciences & Biomedicine
(21)
Male
(16)
Middle Aged
(14)
Female
(13)
Lung Cancer
(12)
Oncology
(10)
Original
(10)
Aged
(9)
Adult
(8)
Lung Neoplasms - Pathology
(7)
Breast Cancer
(6)
Cancer
(6)
Chemotherapy
(6)
Medicine
(6)
Medicine & Public Health
(6)
Risk Factors
(6)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Case-Control Studies
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

Alvopem ® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

Correction to: Mixed-phenotype acute leukemia characteristics: first report from Iran

Proteomic and genomic biomarkers for Non‐Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha‐1 antitrypsin

Circulating free DNA concentration as a marker of disease recurrence and metastatic potential in lung cancer

Mixed-phenotype acute leukemia characteristics: first report from Iran

Correlation of Minichromosome Maintenance Protein 6 Expression Rate and Clinical Outcome in Patients With Hodgkin's Lymphoma

Immunoglobulin Free Light Chains in the Pathogenesis of Lung Disorders

Lung cancer gender differences: An analysis of 1599 patients diagnosed between 1996 and 2018

Cancers Related to Immunodeficiencies: Update and Perspectives

Evaluating the safety and effectiveness of PegaGen.sup.® for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study

Inflammatory Potential of Diet and Odds of Lung Cancer: A Case-Control Study

IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma

Clinical Effectiveness of Erlova in EGFR-Mutated Non-Small Cell Lung Cancer: An Affordable Price with Clinical Benefit

EPA and DHA have selective toxicity for PBMCs from multiple myeloma patients in a partly caspase-dependent manner

Evaluating the safety and effectiveness of PegaGen® (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study

Clinical outcome of Hodgkin lymphoma: A single center study

Non-invasive discrimination of adenocarcinoma and squamous cell carcinoma based on differential expression of miR-944 and miR-326 in sputum samples of lung cancer patients

Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients

Relapse of acute myeloid leukemia as isolated bilateral testicular granulocytic sarcoma in an adult

Cell Free Tumoral DNA Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients with Non-Small Cell Lung Cancer

Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial

A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical Benefit

Dietary Intake and Serum Level of Carotenoids in Lung Cancer Patients: A Case-Control Study

Suchergebnisse filtern